Literature DB >> 11531955

Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination.

U T Hacker1, S Erhardt, K Tschöp, T Jelinek, S Endres.   

Abstract

The inflammatory response in infectious and autoimmune diseases is regulated by the balance between pro- and anti-inflammatory cytokines. The IL-1 complex contains polymorphic genes coding for IL-1alpha, IL-1beta and IL-1Ra. The IL-1Ra (variable number of tanden repeat) VNTR polymorphism has been shown to influence the capacity to produce IL-1beta and IL-1Ra after in vitro stimulation. Allele 2 of this polymorphism is associated with a number of inflammatory diseases. To determine the impact of the IL-1Ra polymorphism on in vivo human cytokine synthesis, we used a yellow fever vaccination model for the induction of cytokine synthesis in healthy volunteers. Two different yellow fever vaccines were used. After administration of the RKI vaccine (34 volunteers), plasma TNF-alpha concentration increased from 13.4 +/- 0.9 pg/ml to 23.3 +/- 1.1 pg/ml (P < 0.001), and plasma IL-1Ra concentration increased from 308 +/- 25 pg/ml to 1019 +/- 111 pg/ml (P < 0.001), on day 2. Using Stamaril vaccine, no increase in the plasma concentrations of either TNF-alpha or IL-1Ra could be detected (n = 17). Only the RKI vaccine induced TNF-alpha synthesis after in vitro stimulation of MNC. Carriers of allele 2 of the IL-1Ra polymorphism had increased baseline concentrations of IL-1Ra (350 +/- 32 pg/ml) compared with non-carriers (222 +/- 18 pg/ml, P < 0.001), and decreased concentrations of IL-1beta (0.9 +/- 0.2 pg/ml for carriers versus 2.8 +/- 0.7 pg/ml for non-carriers, P = 0.017). After yellow fever vaccination (RKI vaccine), no significant differences in the increase of IL-1Ra plasma levels were detected between carriers and non-carriers of allele 2 of the IL-1Ra gene polymorphism. This is the first study to examine the influence of this genetic polymorphism on in vivo-induced human IL-1beta and IL-1Ra synthesis. Baseline concentrations of IL-1Ra and IL-1beta were significantly influenced by the IL-1Ra polymorphism. No influence of the IL-1Ra polymorphism on the in vivo-induced production of IL-1Ra and IL-1beta could be detected.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531955      PMCID: PMC1906142          DOI: 10.1046/j.1365-2249.2001.01621.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

2.  Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis.

Authors:  N A Tountas; V Casini-Raggi; H Yang; F S Di Giovine; M Vecchi; L Kam; L Melani; T T Pizarro; J I Rotter; F Cominelli
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

3.  Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis.

Authors:  J B Crusius; A S Peña; B W Van Oosten; G Bioque; A Garcia; C D Dijkstra; C H Polman
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

4.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.

Authors:  J C Mansfield; H Holden; J K Tarlow; F S Di Giovine; T L McDowell; A G Wilson; C D Holdsworth; G W Duff
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

5.  Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.

Authors:  A I Blakemore; A Cox; A M Gonzalez; J K Maskil; M E Hughes; R M Wilson; J D Ward; G W Duff
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

6.  Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.

Authors:  T Andus; R Daig; D Vogl; E Aschenbrenner; G Lock; S Hollerbach; M Köllinger; J Schölmerich; V Gross
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

7.  Monokine antagonism is reduced in patients with IDDM.

Authors:  T Mandrup-Poulsen; F Pociot; J Mølvig; L Shapiro; P Nilsson; T Emdal; M Røder; L L Kjems; C A Dinarello; J Nerup
Journal:  Diabetes       Date:  1994-10       Impact factor: 9.461

8.  Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.

Authors:  V A Danis; M Millington; V J Hyland; D Grennan
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

9.  Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene.

Authors:  A I Blakemore; P F Watson; A P Weetman; G W Duff
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

Review 10.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

View more
  8 in total

1.  Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

Authors:  Rex Biedenbender; Joan Bevilacqua; Anne M Gregg; Mike Watson; Gustavo Dayan
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 2.  Genetic factors in the pathogenesis of gastroesophageal reflux disease.

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  Indian J Gastroenterol       Date:  2011-05-12

Review 3.  Yellow fever: a reemerging threat.

Authors:  Christina L Gardner; Kate D Ryman
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

4.  A live, attenuated recombinant West Nile virus vaccine.

Authors:  Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Francis A Ennis; Sharone Green; Philip Bedford
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

5.  Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal ureaplasma urealyticum colonization in pregnant women.

Authors:  Parrin T Barton; Stefan Gerber; Daniel W Skupski; Steven S Witkin
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 6.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

Review 7.  Interplay of cytokines in preterm birth.

Authors:  Monika Pandey; Mradula Chauhan; Shally Awasthi
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

Review 8.  Cytokines in bipolar disorder: paving the way for neuroprogression.

Authors:  Izabela Guimarães Barbosa; Moisés Evandro Bauer; Rodrigo Machado-Vieira; Antonio Lucio Teixeira
Journal:  Neural Plast       Date:  2014-09-09       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.